Accendra Health, Inc.
NYSE:ACHMedical - Distribution
Healthcare
$0.71 +3.64%
+$0.12 today
- Market cap
- $54.22M
- Beta
- 1.63
- P/E (TTM)
- -0.2
- EPS (TTM)
- -$14.11
52W Low $1.84High $9.55
Volume 1.41M
Average 0.83M
Income Statement
Follow revenue through to earnings.
Revenue
$2.76B
FY 2025 · Annual
-74.2% YoYOperating Income
$150.16M
FY 2025 · Annual
Net Income
-$1.10B
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 9.79B | 9.96B | 10.33B | 10.7B | 2.76B |
| Cost of Revenue | 8.27B | 8.13B | 8.21B | 8.48B | 1.56B |
| Gross Profit | 1.51B | 1.83B | 2.13B | 2.22B | 1.2B |
| Gross Margin | 15.5% | 18.3% | 20.6% | 20.7% | 43.5% |
| Research & Development | 12.1M | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.08B | 1.55B | 1.81B | 1.91B | 1.05B |
| Operating Expenses | 1.14B | 1.68B | 2.02B | 2.43B | 1.05B |
| Depreciation & Amortization | 90.62M | 228.67M | 287.38M | 264.78M | 214.52M |
| EBITDA | 415.47M | 368.45M | 390.57M | 51.22M | 364.68M |
| EBITDA Margin | 4.2% | 3.7% | 3.8% | 0.5% | 13.2% |
| Operating Income | 368.47M | 142.91M | 104.51M | (207.77M) | 150.16M |
| Operating Margin | 3.8% | 1.4% | 1.0% | -1.9% | 5.4% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 48.09M | 128.89M | 157.92M | 143.8M | 129.2M |
| Other Income / Expenses | (91.72M) | (132.02M) | (159.23M) | (149.59M) | (252.11M) |
| Income Before Tax | 276.75M | 10.89M | (54.73M) | (357.36M) | (101.95M) |
| Pre-Tax Margin | 2.8% | 0.1% | -0.5% | -3.3% | -3.7% |
| Income Tax Expense | 55.17M | (11.5M) | (13.43M) | 5.33M | 729K |
| Net Income | 221.59M | 22.39M | (41.3M) | (362.69M) | (1.1B) |
| Net Margin | 2.3% | 0.2% | -0.4% | -3.4% | -39.8% |
| EPS (Basic) | 3.05 | 0.30 | (0.54) | (4.73) | (14.31) |
| EPS (Diluted) | 2.94 | 0.29 | (0.54) | (4.73) | (14.31) |
| 72.74M | 74.5M | 75.79M | 76.74M | 76.9M | |
| 75.49M | 76.22M | 75.79M | 76.74M | 76.9M |
ACH Earnings Waterfall · TTM
NYSE:ACH · Revenue to Net Income
Key Ratios
EPS$-14.05
Gross Margin41.3%
Net Margin-39.5%
P/E Ratio-2.1
P/S Ratio0.5
Analysis
$2.7B of revenue converted into -$1.1B of net income for the selected period. Gross margin is 41.3% and net margin is -39.5%, showing how much revenue survives after costs and taxes. EPS is $-14.05, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Sep 24, 2026 | |
| 8-K | Current report | Sep 17, 2026 | |
| 8-K | Current report | Aug 17, 2026 | |
| 10-Q | Quarterly report | Aug 10, 2026 | |
| 8-A12B | 8-A12B filing | Aug 10, 2026 |
How much revenue does ACH generate?
Accendra Health, Inc. (ACH) reported $2.76B of revenue in fiscal 2025.
Is ACH profitable?
Accendra Health, Inc. (ACH) reported -$1.10B of net income, with a net margin of -39.8%.
Continue the stock analysis
Jump to another research area for this company.